19-Year-Old's Terminal Brain Tumor Misdiagnosed as Migraines

At 19, Ella-Louise Moroney should be navigating the complexities of young adulthood, not facing a terminal diagnosis. The Peterborough resident, once an early years worker, now battles a rare, aggressive brain tumor that medical professionals initially dismissed. Her journey began in late January with persistent migraines, a condition she had endured since the previous summer. During her first hospital visit, she was given sumatriptan and sent home. A week later, after returning to the same facility with worsening symptoms, she left with Naproxen and another painkiller. The dismissal of her pain as routine migraines raises unsettling questions: Could a young adult's life-threatening condition have been overlooked so easily?

Her partner's mother prepared food during one of these episodes, but Ella-Louise found herself unable to even look at it. Confusion set in, prompting her to contact her mother. This moment proved pivotal. "Something doesn't seem right," her mother insisted. The family then called 111 and rushed her back to the hospital. Even there, doctors appeared prepared to discharge her again. Ella-Louise recounted being sick in a side room, triaged by multiple physicians who offered vague reassurances. It was only after her mother's firm demand for a scan that the hospital finally acted.

The CT scan revealed a tumor in her frontal lobe, but the initial diagnosis stopped short of confirming its malignancy. A biopsy later identified it as a Grade 4 atypical teratoid/rhabdoid tumor (AT/RT), a rare and aggressive cancer with a grim prognosis. Neither her consultant nor oncologist had encountered this type before, compounding the difficulty of treatment. Doctors still attempted to send her home after the scan, despite the growing evidence of a life-threatening condition. "They wanted to discharge me," she said. Her mother's refusal to let that happen was the turning point that saved her life.

Transferred to Addenbrooke's Hospital in Cambridge, Ella-Louise received the devastating news: Without immediate surgery, she had just weeks to live. The procedure took place on February 17, performed by a professor who emphasized the tumor's rapid growth. "We need to go now," he told her. The surgery removed most of the tumor, but the biopsy confirmed the worst: AT/RT, which accounts for less than 1% of all brain tumors and is typically found in children. Its presence in an adult makes treatment even more complex.

Her sister, Deanne Moroney, has launched a GoFundMe campaign to cover medical costs, including travel for appointments and essential devices. The family's ordeal highlights systemic failures in diagnosing rare conditions. How often are symptoms of rare cancers misinterpreted as common ailments? Ella-Louise remains determined, even beginning egg harvesting for future use. Her story is a stark reminder of the risks faced by patients whose conditions fall through the cracks of routine care. The road ahead is uncertain, but her resilience offers a glimmer of hope in an otherwise harrowing journey.

Ms Moroney's battle with a rare and aggressive form of brain cancer has become a stark reminder of how medical mysteries can challenge even the most advanced healthcare systems. At just 24, she faces a Grade 4 atypical teratoid/rhabdoid tumour (AT/RT) in her frontal lobe—a condition so uncommon in adults that it typically affects children under five. "After surgery, most of the tumour was removed, but chemotherapy and radiotherapy are still very much needed," she said, her voice steady despite the weight of her words. The diagnosis has left her family grappling with questions no one can How does one cope when the medical field itself lacks the data to guide treatment?

The rarity of AT/RT in adults has left doctors and researchers scrambling for solutions. "There's hardly any cases that are documented, which is why treatment is quite tricky," said her consultant. "They just don't really have a lot of information on my age range because it's normally children that are so young." This lack of data has created a paradox: a tumour that demands aggressive intervention but lacks the clinical trials and protocols to support it. Both her consultant and oncologist admitted they had never encountered such a case in their careers—a revelation that left Ms Moroney in disbelief. "It is very hard news to take in because there's not enough research into it," she said. "It is very hard to kind of sit back and just have to accept the fact that we just don't know anything."

Her treatment plan, though grim, reflects a determined effort to fight. Starting in early April, she will undergo eight weeks of chemotherapy at UCL Hospital in London, followed by proton radiotherapy, and then another round of chemo. "I am having my eggs harvested at the moment," she explained, "which is postponing the chemotherapy and radiation. But that treatment is due to start in early April." Despite the physical toll, Ms Moroney remains resolute. "As much as I can, I try and make a joke out of it kind of thing because if not, there's nothing else that I can do." Her optimism, she said, stems from trusting her medical team: "I know that the doctors are doing everything that they can, and obviously I'm getting the best treatment that I can."

The physical aftermath of surgery has been equally challenging. While her migraines have vanished—a relief she described as "crazy"—she now faces new hurdles. "I haven't had any headaches since I had surgery," she said. "But because I'm still recovering from the brain surgery, I am still quite slow and my walking has changed quite a lot as well. Like I've just had really messed up knees. I'll wake up some mornings and my knees will just be in like excruciating pain." These daily battles underscore the complexity of her recovery, where each step forward feels like a small victory.

Behind the scenes, her family's financial strain has grown with every passing day. Travel costs, medical bills, and the need for a wheelchair have created a burden that no one should have to face alone. Sister Deanne, who launched a GoFundMe campaign targeting £9,000, spoke emotionally about their plight: "I set the fundraiser up in hopes to raise some money to support the costs of travel, medical expenses and things like a wheelchair for Ella." The campaign has already exceeded expectations, drawing support from strangers across the globe. Yet, Deanne emphasized the deeper goal: "We also want to raise brain cancer awareness."

As Ms Moroney prepares for the next phase of her treatment, her story raises urgent questions about rare diseases and the gaps in medical research. How many others are facing similar battles without the resources to fight? Can society do more to support patients whose conditions fall through the cracks of conventional care? For now, Ms Moroney's resilience offers a glimmer of hope. "I am as optimistic as much as I can," she said. "Because even in the darkest moments, there are still people who believe in you.